JP2017514507A - 免疫適合性のある絨毛膜生成物 - Google Patents

免疫適合性のある絨毛膜生成物 Download PDF

Info

Publication number
JP2017514507A
JP2017514507A JP2016566889A JP2016566889A JP2017514507A JP 2017514507 A JP2017514507 A JP 2017514507A JP 2016566889 A JP2016566889 A JP 2016566889A JP 2016566889 A JP2016566889 A JP 2016566889A JP 2017514507 A JP2017514507 A JP 2017514507A
Authority
JP
Japan
Prior art keywords
membrane
chorion
cells
amount
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016566889A
Other languages
English (en)
Japanese (ja)
Inventor
サムソン トム
サムソン トム
アラ ダニルコヴィッチ
アラ ダニルコヴィッチ
ダナ ヨー
ダナ ヨー
ティモシー ジャンセン
ティモシー ジャンセン
ジン−チアン クアン
ジン−チアン クアン
ジェニファー ミシェル マルコリーニ
ジェニファー ミシェル マルコリーニ
Original Assignee
オシリス セラピューティクス，インコーポレイテッド
オシリス セラピューティクス，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オシリス セラピューティクス，インコーポレイテッド, オシリス セラピューティクス，インコーポレイテッド filed Critical オシリス セラピューティクス，インコーポレイテッド
Publication of JP2017514507A publication Critical patent/JP2017514507A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
JP2016566889A 2014-05-07 2014-05-07 免疫適合性のある絨毛膜生成物 Pending JP2017514507A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/037204 WO2015171143A1 (en) 2014-05-07 2014-05-07 Immunocompatible chorionic membrane products

Publications (1)

Publication Number Publication Date
JP2017514507A true JP2017514507A (ja) 2017-06-08

Family

ID=54392805

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016566889A Pending JP2017514507A (ja) 2014-05-07 2014-05-07 免疫適合性のある絨毛膜生成物

Country Status (7)

Country Link
EP (1) EP3139934A4 (de)
JP (1) JP2017514507A (de)
KR (1) KR20160149292A (de)
AU (1) AU2014393403A1 (de)
CA (1) CA2948129A1 (de)
SG (1) SG11201609253PA (de)
WO (1) WO2015171143A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017514879A (ja) * 2014-05-07 2017-06-08 オシリス セラピューティクス，インコーポレイテッド 免疫適合性のある羊膜生成物
JP2017531653A (ja) * 2014-10-07 2017-10-26 ニューテック メディカル インコーポレイテッド 胎盤組織の低温貯蔵のための方法および組成物

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2663720T3 (es) 2010-02-18 2018-04-16 Osiris Therapeutics, Inc. Métodos de fabricación de productos terapéuticos que comprenden dispersiones placentarias vitalizadas
WO2018039294A1 (en) 2016-08-24 2018-03-01 Arthrex, Inc. Tissue use for repair of injury
CN108721606A (zh) * 2018-06-08 2018-11-02 广东唯泰生物科技有限公司 一种基于干细胞生长因子的妊娠纹修复产品及其制备方法
US11511017B2 (en) 2019-03-12 2022-11-29 Arthrex, Inc. Ligament reconstruction

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110206776A1 (en) * 2010-02-18 2011-08-25 Samson Tom Methods of manufacture of immunocompatible amniotic membrane products
JP2017514879A (ja) * 2014-05-07 2017-06-08 オシリス セラピューティクス，インコーポレイテッド 免疫適合性のある羊膜生成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058495A2 (en) * 2000-02-11 2001-08-16 The General Hospital Corporation Photochemical tissue bonding
US8632512B2 (en) * 2010-04-09 2014-01-21 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110206776A1 (en) * 2010-02-18 2011-08-25 Samson Tom Methods of manufacture of immunocompatible amniotic membrane products
JP2017514879A (ja) * 2014-05-07 2017-06-08 オシリス セラピューティクス，インコーポレイテッド 免疫適合性のある羊膜生成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EUROPEAN CELLS AND MATERIALS (2008) VOL.15, PP.88-99, JPN6018018317 *
INTERNATIONAL WOUND JOURNAL (2013) VOL.10, PP.493-500, JPN7018001606 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017514879A (ja) * 2014-05-07 2017-06-08 オシリス セラピューティクス，インコーポレイテッド 免疫適合性のある羊膜生成物
JP2017531653A (ja) * 2014-10-07 2017-10-26 ニューテック メディカル インコーポレイテッド 胎盤組織の低温貯蔵のための方法および組成物

Also Published As

Publication number Publication date
EP3139934A4 (de) 2017-11-15
KR20160149292A (ko) 2016-12-27
WO2015171143A1 (en) 2015-11-12
AU2014393403A1 (en) 2016-11-24
SG11201609253PA (en) 2016-12-29
EP3139934A1 (de) 2017-03-15
CA2948129A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
US11510947B2 (en) Methods of manufacture of immunocompatible amniotic membrane products
US20150010610A1 (en) Immunocompatible amniotic membrane products
US20150010609A1 (en) Immunocompatible chorionic membrane products
JP2017514876A (ja) 治療用胎盤組成物、その製造法及び使用法
US20150010506A1 (en) Therapeutic placental compositions, methods of making and methods of use
JP2017514507A (ja) 免疫適合性のある絨毛膜生成物
JP2017514879A (ja) 免疫適合性のある羊膜生成物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170508

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180522

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180806

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190108